Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dova Pharmaceuticals Inc.

www.dova.com

Latest From Dova Pharmaceuticals Inc.

UCB To Buy Ra for $2.1bn And Plays Down Antitrust Fears

The deal, welcomed by analysts, means that the Belgian drug maker has two late-stage products for the rare disease myasthenia gravis to challenge Alexion's Soliris.
M & A Companies

Sobi Targets Thrombocytopenia In $915m Swoop For Dova

The Swedish group has got hold of the ITP and CLD drug Doptelet, widening its hematology business beyond hemophilia.

M & A Blood & Coagulation Disorders

New EU Approvals

The Pink Sheet’s list of EU centralized approvals of new active substances now includes four new products, one of which is Regeneron Pharmaceuticals/Sanofi’s Libtayo (cemiplimab) for treating advanced cutaneous squamous cell carcinoma. The list, which contains information dating back to January 2018, includes brand name, generic name, company, therapeutic indication, date of marketing authorization and product type (eg, medicine, vaccine, biologic).

Approvals Europe

Keeping Track: US FDA Closes Out First Half Of 2019 With CRL For Edsivo, But A Burst Of Supplemental Approvals

The latest drug development news and highlights from our US FDA Performance Tracker.

Approvals Drug Review
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Hepatic (Liver)
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • Dova Pharmaceuticals Inc.
  • Senior Management
  • David Zaccardelli, Pres. & CEO
    Mark W Hahn, CFO
    Lee Allen, CMO
    Jason Hoitt, Chief Commercial Officer
  • Contact Info
  • Dova Pharmaceuticals Inc.
    Phone: (844) 506-3682
    240 Leigh Farm Rd., Ste. 245
    Durham, NC 27707
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register